Outcomes and evidence
Clinical, operational, or patient-experience data with a clear method, ideally peer-reviewed or independently validated.
For venture-backed digital health and health tech companies, and multi-location care groups. We earn coverage in the health trades and national outlets your buyers read, with clinician spokespeople and claims your regulatory team has already reviewed.
The stakes
Health coverage carries more scrutiny than almost any other beat. Reporters, health system buyers, and patients expect evidence, qualified spokespeople, and care with patient information. Getting it right earns trust that is hard for competitors to copy.
In KFF's Tracking Poll on Health Information and Trust, fielded June 25 to 30, 2026, 86% of adults said they trust their own doctor or health care provider at least a fair amount for health information.Source: KFF
What goes wrong
Where healthcare stories land
A starting list. Every program is built from your buyers' reading habits and the reporters who have covered your category in the last two quarters.
| Outlet | Type | What earns a story |
|---|---|---|
| STAT | National health and biotech | Evidence, policy, and biopharma stories; First Opinion requires conflict disclosure |
| Modern Healthcare | Health system trade | Staff-reported news for hospital, system, and insurer executives |
| Fierce Healthcare | Provider and payer trade | Beat news via tips, and perspective-led Industry Voices |
| MedCity News | Health innovation trade | Health tech business stories and non-product contributor pieces |
| Axios | Business and policy newsletters | Deals, policy, and market movement in health |
Outlet names link to our media directory profiles, with coverage focus and official routes in.
What earns coverage
Clinical, operational, or patient-experience data with a clear method, ideally peer-reviewed or independently validated.
Physicians and clinical leaders as spokespeople and authors, prepared for reporters' evidence questions.
Expert commentary when CMS, FDA, or payer decisions change how care is delivered or paid for.
For multi-location groups: access, expansion, and community outcomes in regional business and health press.
Guardrails
Which guardrails apply depends on what you sell and whether you are a covered entity. We bring regulatory and legal review in early. A starting point, not legal advice:
| Rule | Applies to | What it means for PR |
|---|---|---|
| HIPAA marketing rule, 45 CFR 164.508(a)(3) | Covered entities and business associates | Written patient authorization before using any patient's health information in marketing, with narrow exceptions. |
| FTC Health Products Compliance Guidance | Health claims in ads, releases, and posts | Health benefit claims generally need competent and reliable scientific evidence; disclose material connections with endorsers. |
| FDA prescription drug promotion (OPDP) | Prescription drugs; device makers face parallel FDA rules | Claims must be consistent with FDA-approved or cleared labeling; route product communications through regulatory review. |
How the program runs
Every claim mapped to its evidence and to the review it needs, before messaging is written.
Briefings and media training for the clinical voices reporters trust most.
Health system buyers, employers, patients, and investors read different outlets; we follow each outlet's published contributor rules.
For care groups, consistent profiles and local coverage so search and AI assistants describe every location accurately.
Go deeper
MULTI-LOCATION CARE GROUP
A 10+ clinic group outpaced a VC-backed DSO. Regional press, a founder byline, creators, and GEO lifted new-patient bookings 41 percent.
Read case studyMEDIA DIRECTORY
Pitching profiles with coverage focus and official routes in, including the outlets above.
Browse the directoryEngagements
PROJECT
From
$25,000 / project
A launch, a raise, or a major announcement.
See launch detailsRETAINER
From
$15,000 / month
Ongoing PR, thought leadership, and AEO/GEO. Six-month minimum.
See retainer detailsNot a fit: pre-product startups, companies without a clear category, one-off press release distribution, or budgets under $15,000 per month or $25,000 per project.
Questions
Yes. Health claims, patient stories, and product communications go through the review path you already use, and we build that time into every plan rather than asking for approval the night before.
Sometimes, with care. Covered entities need written patient authorization before using health information in marketing, and every story needs consent and review. Clinician perspectives and aggregate outcomes are often stronger and simpler.
Yes. Care groups need regional coverage, consistent local profiles, and accurate descriptions in search and AI answers for every location. Our page for enterprise and multi-location brands covers the broader program.
Tier-One Launch campaigns start from $25,000 per project. The Authority Retainer for ongoing PR, thought leadership, and AEO/GEO starts from $15,000 per month with a six-month minimum. Every engagement is led by a partner.
No. Editors decide coverage, and any agency that guarantees it is selling something else. We commit to the work: a story worth an editor's time, the right reporters, the right timing, and a partner who runs the program.
Related reading
National stories with local proof for multi-location care groups.
ReadAnswering publicly without confirming anyone is a patient.
ReadWorking with health trades and their contributor rules.
ReadOther industries: Fintech PR, Cybersecurity PR, B2B SaaS PR, Climate tech PR.